👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Sharapova owed apology from WADA, her lawyer says

Published 20/06/2016, 23:54
© Reuters. Sharapova of Russia speaks during a news conference at the Brisbane International tennis tournament

(Reuters) - Maria Sharapova's lawyer has blasted WADA chief Craig Reedie for making remarks about the five-times grand slam champion at a conference in London on Monday and said the Russian tennis player was owed an apology.

The criticism came in a statement by Sharapova's management company, IMG, after Reedie commented at a World Anti-Doping Agency conference on Sharapova, who is serving a two-year ban after testing positive for the prohibited substance meldonium.

"For me the only satisfactory element in Madame Sharapova's case was that in one year she can earn more money than the whole of WADA’s budget put together," Reedie said.

Reedie made his comments relating to Sharapova as he was making a call for more governments and TV broadcasters to pitch in extra money to WADA's campaign for clean sport.

Sharapova's lawyer, John Haggerty, took exception to Reedie's comments, which he called unprofessional.

"Justice, whether in the eyes of WADA or a court, must be blind, including being blind to a player's earnings," Haggerty said in a statement.

"Mr. Reedie owes an apology to Maria and to all successful tennis players unless he wants fans to think WADA has different standards for players depending on their ranking and earnings."

CLEAN SPORT

WADA told Reuters that Reedie's comments at WADA's annual Media Symposium were made in the context of a debate on further funding for clean sport and drew comparisons between WADA's annual budget and the earning of various sportsmen and women.

"His comments have absolutely no bearing on any particular anti-doping case," said WADA spokesman Ben Nichols.

WADA said last week it would not file an appeal to the Court of Arbitration for Sport (CAS) after reviewing the ruling on Sharapova's two-year ban by the International Tennis Federation.

WADA could have petitioned for either a harsher or more lenient punishment.

Sharapova stunned the sporting world in March when she announced she had tested positive for the heart medication meldonium, which was added to WADA's banned list on Jan. 1.

The Russian had been the highest paid woman in sports for the last 11 years until her reign ended shortly after news of her positive test.

She is now second on Forbes' list of the highest-paid female athletes, behind fellow tennis player Serena Williams, with combined prize money and off-field earnings of $28.9 million over the last 12 months.

© Reuters. Sharapova of Russia speaks during a news conference at the Brisbane International tennis tournament

Sharapova, 29, has appealed her two-year ban to CAS.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.